External validation of individual risk calculator to predict lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinomaMain study

Every year, hundreds of patients face a brutal choice after having an early oesophageal tumour removed: gamble on a watch-and-wait strategy, or undergo an oesophagectomy—a major operation to remove part of the gullet that carries a 2–5% risk of dying on the table and a high chance of long-term complications. The dilemma is that most surgical specimens show no remaining cancer or spread to lymph nodes, meaning many patients endure a life-altering operation they never needed. Clinicians currently rely on individual tumour features—depth of invasion, differentiation grade, lymphatic invasion—to estimate risk of lymph node metastasis, but no tool combines these features into a personalised prediction for an individual patient. This project externally validates a risk calculator developed from a Dutch nationwide cohort of 248 patients with T1b oesophageal adenocarcinoma. If the calculator proves accurate in a separate UK population, it could give clinicians and patients a concrete, evidence-based number: your personal risk of lymph node spread is X%. For patients whose predicted risk falls below the mortality rate of surgery, the calculator would support a safe endoscopic surveillance pathway, sparing them the physical and psychological toll of an unnecessary oesophagectomy. For those with higher risk, it would justify proceeding to surgery with greater confidence. The tool would not replace clinical judgment but would sharpen it, reducing both overtreatment and undertreatment in a disease where the stakes are life and death.